====== AICAR 240μM R05 exp211 ======
==== Mechanism of Action ====
Metabolic intermediate in purine biosynthesis, activates AMPK, has other putative targets
* **Class / Subclass 1:** Metabolism / Metabolite
* **Class / Subclass 2:** Signal Transduction / Kinase Activator
==== Technical Notes ====
* **PubChem Name:** %%Acadesine%%
* **Synonyms:** Acadesine; AICA Riboside
* **CAS #:** 2627-69-2
* **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/17513|17513]]
* **IUPAC:** %%5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazole-4-carboxamide%%
* **INCHI Name:** InChI=1S/C9H14N4O5/c10-7-4(8(11)17)12-2-13(7)9-6(16)5(15)3(1-14)18-9/h2-3,5-6,9,14-16H,1,10H2,(H2,11,17)/t3-,5-,6-,9-/m1/s1
* **INCHI Key:** RTRQQBHATOEIAF-UUOKFMHZSA-N
* **Molecular Weight:** 258.23
* **Canonical SMILES:** C1=NC(=C(N1C2C(C(C(O2)CO)O)O)N)C(=O)N
* **Isomeric SMILES:** C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N)C(=O)N
* **Molecular Formula:** C9H14N4O5
{{:chemogenomics:structures:chem-0072.svg?nolink}}
* **Supplier Name:** AK scientific
* **Catalog #:** AMTNS043
* **Lot #:** DM-079-143-2
* **LCMS:** Tr 0.15 min, m/z 259+ [M+H]+, 257- [M-H]-
* **Platform ID:** AICAR
* **Min:** -11.2747; **Max:** 24.1473
{{:chemogenomics:dose_response:dr_68.png?nolink&500 |}}
\\
\\
\\
\\
|< 300px 100px 200px >|
^ IC ^ Concentration (µM) ^
| IC10 |N/A |
| IC20 |N/A |
| IC30 |N/A |
| IC40 |N/A |
| IC50 |N/A |
| IC60 |N/A |
| IC70 |N/A |
| IC80 |N/A |
| IC90 |N/A |
\\
==== Screen Summary ====
* **Round**: 05
* **Dose**: 240µM
* **Days of incubation**: 8
* **Doublings**: 1.5
* **Numbers of reads**: 17899422
==== Screen Results ====
^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|1/115|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/AICAR_240uM_Round-5_exp211.txt|Scores]]||||||
{{:chemogenomics:cranks_plots:exp211.png?nolink}}
^Gene^CRANKS Score^FDR^
|[[:human_genes:U:UCK2|UCK2]]|-4.28|<0.01|
|[[:human_genes:R:RPL30|RPL30]]|-2.80|0.37|
|[[:human_genes:S:SKIV2L2|SKIV2L2]]|-2.70|0.39|
|[[:human_genes:U:UGDH|UGDH]]|-2.68|0.06|
|[[:human_genes:N:NPRL2|NPRL2]]|-2.64|0.06|
|[[:human_genes:U:USP5|USP5]]|-2.63|0.10|
|[[:human_genes:C:CREBBP|CREBBP]]|-2.60|0.10|
|[[:human_genes:P:PPP1R18|PPP1R18]]|-2.48|0.26|
|[[:human_genes:G:GNL3|GNL3]]|-2.47|0.20|
|[[:human_genes:N:NUP133|NUP133]]|-2.43|0.26|
|[[:human_genes:D:DNAH3|DNAH3]]|-2.41|0.19|
|[[:human_genes:S:SUPT3H|SUPT3H]]|-2.40|0.10|
|[[:human_genes:T:TK1|TK1]]|-2.40|0.10|
|[[:human_genes:R:RPS13|RPS13]]|-2.27|0.44|
|[[:human_genes:N:NIPBL|NIPBL]]|-2.27|0.26|
|[[:human_genes:T:TRIM44|TRIM44]]|-2.27|0.20|
|[[:human_genes:Z:ZNF259|ZNF259]]|-2.26|0.20|
|[[:human_genes:H:HMGCS1|HMGCS1]]|-2.21|0.28|
|[[:human_genes:Y:YBX3|YBX3]]|-2.21|0.25|
|[[:human_genes:D:DTYMK|DTYMK]]|-2.20|0.25|
|[[:human_genes:S:SRSF10|SRSF10]]|-2.19|0.29|
|[[:human_genes:U:UBE2D3|UBE2D3]]|-2.19|0.20|
|[[:human_genes:T:TRIM66|TRIM66]]|-2.19|0.20|
|[[:human_genes:K:KRTAP4-8|KRTAP4-8]]|-2.18|0.35|
|[[:human_genes:M:MIER3|MIER3]]|-2.16|0.20|
|[[:human_genes:C:CHMP6|CHMP6]]|-2.16|0.26|
|[[:human_genes:F:F7|F7]]|-2.15|0.20|
|[[:human_genes:C:COX7A2|COX7A2]]|-2.15|0.20|
|[[:human_genes:C:CMPK1|CMPK1]]|-2.15|0.20|
|[[:human_genes:L:LSM6|LSM6]]|-2.14|0.30|
|[[:human_genes:L:LIAS|LIAS]]|3.38|<0.01|
|[[:human_genes:A:ATIC|ATIC]]|3.38|<0.01|
|[[:human_genes:M:MAPKAP1|MAPKAP1]]|3.38|<0.01|
|[[:human_genes:G:GUK1|GUK1]]|3.41|<0.01|
|[[:human_genes:F:FDX1|FDX1]]|3.42|<0.01|
|[[:human_genes:M:MARCH5|MARCH5]]|3.44|<0.01|
|[[:human_genes:M:MLX|MLX]]|3.49|<0.01|
|[[:human_genes:M:MLST8|MLST8]]|3.53|<0.01|
|[[:human_genes:A:APAF1|APAF1]]|3.61|<0.01|
|[[:human_genes:H:HEATR3|HEATR3]]|3.65|<0.01|
|[[:human_genes:T:TP53|TP53]]|3.95|<0.01|
|[[:human_genes:B:BAK1|BAK1]]|3.97|<0.01|
|[[:human_genes:S:SLC25A51|SLC25A51]]|4.28|<0.01|
|[[:human_genes:M:MTRR|MTRR]]|4.37|<0.01|
|[[:human_genes:P:PRUNE|PRUNE]]|4.55|<0.01|
|[[:human_genes:M:MTHFD1L|MTHFD1L]]|4.89|<0.01|
|[[:human_genes:M:MTR|MTR]]|4.96|<0.01|
|[[:human_genes:D:DLD|DLD]]|4.99|<0.01|
|[[:human_genes:Y:YLPM1|YLPM1]]|5.03|<0.01|
|[[:human_genes:S:SLC29A1|SLC29A1]]|5.11|<0.01|
|[[:human_genes:S:SLC19A1|SLC19A1]]|5.15|<0.01|
|[[:human_genes:A:ADSS|ADSS]]|5.35|<0.01|
|[[:human_genes:M:MMACHC|MMACHC]]|5.43|<0.01|
|[[:human_genes:M:MTHFD2|MTHFD2]]|5.45|<0.01|
|[[:human_genes:S:SHMT2|SHMT2]]|5.57|<0.01|
|[[:human_genes:S:SLC25A32|SLC25A32]]|6.31|<0.01|
|[[:human_genes:I:IMPDH2|IMPDH2]]|7.40|<0.01|
|[[:human_genes:A:AK2|AK2]]|8.09|<0.01|
|[[:human_genes:N:NUDT2|NUDT2]]|8.48|<0.01|
|[[:human_genes:A:ADK|ADK]]|8.50|<0.01|
^Screen^Correlation^Plot^
|[[:results:exp456|Benzoate 20000μM R08 exp456]]|0.128||
|[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|0.115||
|[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|0.111||
|[[:results:exp135|MS023 7μM R03 exp135]]|0.109||
|[[:results:exp512|Olaparib 4μM R08 exp512]]|0.104||
|[[:results:exp199|Etoposide 0.3μM R05 exp199]]|0.101||
|[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|0.098||
|[[:results:exp451|Atovaquone 15μM R08 exp451]]|0.097||
|[[:results:exp134|MS023 2μM R03 exp134]]|0.094||
|[[:results:exp80|RO-3307 4.7μM R02 exp80]]|0.091||
|[[:results:exp531|THZ1 0.06μM R08 exp531]]|0.09||
|[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|0.087||
|[[:results:exp485|GSK626616 14μM R08 exp485]]|0.087||
|[[:results:exp472|CI-1040 9.5μM R08 exp472]]|0.081||
|[[:results:exp474|CR131-b 0.005μM R08 exp474]]|0.08||
|[[:results:exp459|Bleomycin 5μM R08 exp459]]|0.079||
|[[:results:exp34|Rotenone 20μM R00 exp34]]|0.078||
|[[:results:exp106|UM131593 0.2μM R03 exp106]]|0.077||
|[[:results:exp450|Artemisinin 50μM R08 exp450]]|0.076||
|[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|0.075||
|[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|0.074||
|[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|0.073||
|[[:results:exp19|Etoposide 1μM R00 exp19]]|0.071||
|[[:results:exp515|PU-H71 1μM R08 exp515]]|0.071||
|[[:results:exp527|Tanespimycin 14μM R08 exp527]]|0.07||
|[[:results:exp505|ML-792 0.2μM R08 exp505]]|0.07||
|[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|0.068||
|[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|0.068||
|[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|0.066||
|[[:results:exp435|JQ1 0.8μM R08 exp435]]|0.066||
|[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|0.065||
|[[:results:exp350|Deferoxamine 11μM R07 exp350]]|0.064||
|[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|0.063||
|[[:results:exp443|SNS-032 15μM R08 exp443]]|0.062||
|[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|0.061||
|[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|0.061||
|[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|0.061||
|[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|0.06||
|[[:results:exp234|Ethanol 0.01 R05 exp234]]|0.058||
|[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|0.057||
|[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|0.057||
|[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|0.057||
|[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|0.054||
|[[:results:exp85|UM0129480 7μM R02 exp85]]|0.053||
|[[:results:exp499|LY2090314 0.003μM R08 exp499]]|0.052||
|[[:results:exp264|Arsenate 40μM R06 exp264]]|0.052||
|[[:results:exp468|CB-5083 0.4μM R08 exp468]]|0.051||
|[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|0.051||
|[[:results:exp431|Rotenone 0.07μM R08 exp431]]|0.051||
|[[:results:exp116|AICAR 240μM R03 exp116]]|0.209||
|[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|0.114||
|[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|0.076||
|[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|0.051||
{{:chemogenomics:comparison_plots:exp211_vs_exp456.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp440.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp3.png?nolink |}}
{{:chemogenomics:comparison_plots:exp135_vs_exp211.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp512.png?nolink |}}
{{:chemogenomics:comparison_plots:exp199_vs_exp211.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp503.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp451.png?nolink |}}
{{:chemogenomics:comparison_plots:exp134_vs_exp211.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp80.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp531.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp478.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp485.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp472.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp474.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp459.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp34.png?nolink |}}
{{:chemogenomics:comparison_plots:exp106_vs_exp211.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp450.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp524.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp294.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp488.png?nolink |}}
{{:chemogenomics:comparison_plots:exp19_vs_exp211.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp515.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp527.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp505.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp489.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp529.png?nolink |}}
{{:chemogenomics:comparison_plots:exp21_vs_exp211.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp435.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp448.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp350.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp441.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp443.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp28.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp354.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp374.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp35.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp234.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp355.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp329.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp500.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp36.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp85.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp499.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp264.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp468.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp414.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp431.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp211.png?nolink |}}
{{:chemogenomics:comparison_plots:exp2_vs_exp211.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp259.png?nolink |}}
{{:chemogenomics:comparison_plots:exp211_vs_exp214.png?nolink |}}
^GO Term^Fold Change^Genes^
|thymidine metabolic process|285.69|TK1,DTYMK|
|nucleoside kinase activity|214.27|UCK2,TK1,CMPK1|
|pyrimidine nucleotide biosynthetic process|57.14|UCK2,DTYMK,CMPK1|
|pyrimidine-containing compound biosynthetic process|57.14|UCK2,TK1,DTYMK,CMPK1|
|nucleobase-containing compound kinase activity|55.74|UCK2,TK1,DTYMK,CMPK1|
^GO Term^Fold Change^Genes^
|tetrahydrofolate metabolic process|197.26|SHMT2,MTHFD2,MTR,MTHFD1L,ATIC|
|AMP biosynthetic process|184.11|ADK,NUDT2,ADSS2,ATIC|
|folic acid-containing compound metabolic process|154.65|SHMT2,MTHFD2,SLC19A1,MTR,MTHFD1L,MTRR,ATIC|
|purine ribonucleoside monophosphate biosynthetic process|153.43|ADK,NUDT2,IMPDH2,ADSS2,ATIC|
|pteridine-containing compound metabolic process|142.54|SLC25A32,SHMT2,MTHFD2,SLC19A1,MTR,MTHFD1L,MTRR,ATIC|
|purine nucleoside monophosphate biosynthetic process|138.08|ADK,NUDT2,IMPDH2,ADSS2,ATIC|
|purine ribonucleoside monophosphate metabolic process|96.66|ADK,NUDT2,AK2,IMPDH2,ADSS2,GUK1,ATIC|
|purine nucleoside monophosphate metabolic process|92.06|ADK,NUDT2,AK2,IMPDH2,ADSS2,GUK1,ATIC|
|ribonucleoside monophosphate biosynthetic process|81.23|ADK,NUDT2,IMPDH2,ADSS2,ATIC|
|water-soluble vitamin metabolic process|66.66|SLC25A32,SHMT2,MTHFD2,MMACHC,SLC19A1,MTR,MTRR|
|ribonucleoside monophosphate metabolic process|65.53|ADK,NUDT2,AK2,IMPDH2,ADSS2,GUK1,ATIC|
|nucleoside monophosphate metabolic process|50.87|ADK,NUDT2,AK2,IMPDH2,ADSS2,GUK1,ATIC|
|dicarboxylic acid metabolic process|50.21|SLC25A32,SHMT2,MTHFD2,ADSS2,SLC19A1,MTHFD1L,MTRR,ATIC|
|vitamin metabolic process|39.86|SLC25A32,SHMT2,MTHFD2,MMACHC,SLC19A1,MTR,MTRR|
|cellular modified amino acid metabolic process|38.76|SLC25A32,SHMT2,MTHFD2,SLC19A1,MTR,MTHFD1L,MTRR,ATIC|
|purine-containing compound biosynthetic process|22.49|ADK,NUDT2,AK2,IMPDH2,SHMT2,ADSS2,DLD,GUK1,ATIC|
|purine nucleotide biosynthetic process|20.84|ADK,NUDT2,AK2,IMPDH2,ADSS2,DLD,GUK1,ATIC|
|carboxylic acid metabolic process|8.21|SLC25A32,SHMT2,MTHFD2,ADSS2,SLC19A1,DLD,MTR,MTHFD1L,MTRR,TP53,ATIC,LIAS|
|oxoacid metabolic process|8.00|SLC25A32,SHMT2,MTHFD2,ADSS2,SLC19A1,DLD,MTR,MTHFD1L,MTRR,TP53,ATIC,LIAS|